These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8627528)

  • 21. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY; Kim GY; Kim ND; Jung JH; Kim SK; Kang HS; Choi YH
    Oncol Rep; 2008 Feb; 19(2):517-26. PubMed ID: 18202802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tirapazamine cytotoxicity for neuroblastoma is p53 dependent.
    Yang B; Reynolds CP
    Clin Cancer Res; 2005 Apr; 11(7):2774-80. PubMed ID: 15814660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bcl-2 expression in neuroblastoma is differentially regulated by differentiation inducers.
    Kim CJ; Kim HO; Choe YJ; Lee YA; Kim CW
    Anticancer Res; 1995; 15(5B):1997-2000. PubMed ID: 8572591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P53 mediates ceramide-induced apoptosis in SKN-SH cells.
    Kim SS; Chae HS; Bach JH; Lee MW; Kim KY; Lee WB; Jung YM; Bonventre JV; Suh YH
    Oncogene; 2002 Mar; 21(13):2020-8. PubMed ID: 11960374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doxorubicin-induced death in neuroblastoma does not involve death receptors in S-type cells and is caspase-independent in N-type cells.
    Hopkins-Donaldson S; Yan P; Bourloud KB; Muhlethaler A; Bodmer JL; Gross N
    Oncogene; 2002 Sep; 21(39):6132-7. PubMed ID: 12203125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cells from baxalpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53.
    Brady HJ; Salomons GS; Bobeldijk RC; Berns AJ
    EMBO J; 1996 Mar; 15(6):1221-30. PubMed ID: 8635454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells.
    Kim MS; Kim CJ; Jung HS; Seo MR; Juhnn YS; Shin HY; Ahn HS; Thiele CJ; Chi JG
    J Pathol; 2004 Jan; 202(1):103-12. PubMed ID: 14694527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines.
    Isaacs JS; Hardman R; Carman TA; Barrett JC; Weissman BE
    Cell Growth Differ; 1998 Jul; 9(7):545-55. PubMed ID: 9690622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells.
    Zhang X; Xu LS; Wang ZQ; Wang KS; Li N; Cheng ZH; Huang SZ; Wei DZ; Han ZG
    FEBS Lett; 2004 Jul; 570(1-3):7-12. PubMed ID: 15251430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
    Walker A; Taylor ST; Hickman JA; Dive C
    Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological and biochemical changes induced by arsenic trioxide in neuroblastoma cell lines.
    Ryu KH; Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Kie JH; Shin HY; Ahn HS
    Pediatr Hematol Oncol; 2005; 22(7):609-21. PubMed ID: 16166054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-Myc overexpression leads to decreased beta1 integrin expression and increased apoptosis in human neuroblastoma cells.
    van Golen CM; Soules ME; Grauman AR; Feldman EL
    Oncogene; 2003 May; 22(17):2664-73. PubMed ID: 12730680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line.
    Nakamura Y; Ozaki T; Niizuma H; Ohira M; Kamijo T; Nakagawara A
    Biochem Biophys Res Commun; 2007 Mar; 354(4):892-8. PubMed ID: 17276397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma.
    Sun Y; Tran BN; Worley LA; Delston RB; Harbour JW
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1561-4. PubMed ID: 15851551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F; Bae I; Fornace AJ; Pommier Y
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells.
    Voigt A; Zintl F
    Med Pediatr Oncol; 2003 Apr; 40(4):205-13. PubMed ID: 12555246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human neuroblastoma I-type cells are malignant neural crest stem cells.
    Ross RA; Spengler BA; Domènech C; Porubcin M; Rettig WJ; Biedler JL
    Cell Growth Differ; 1995 Apr; 6(4):449-56. PubMed ID: 7794812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential collagen biosynthesis by human neuroblastoma cell variants.
    DeClerck YA; Bomann ET; Spengler BA; Biedler JL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6505-10. PubMed ID: 2445473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coordinate changes in neuronal phenotype and surface antigen expression in human neuroblastoma cell variants.
    Rettig WJ; Spengler BA; Chesa PG; Old LJ; Biedler JL
    Cancer Res; 1987 Mar; 47(5):1383-9. PubMed ID: 3028608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.